This announcement is a separate document:
国浩律师（上海）事务所关于湖北济川药业股份有限公司2022年限制性股票与股票期权激励计划注销部分股票期权并回购注销部分限制性股票之法律意见书
Legal Opinion of Guohao Law Firm (Shanghai) on the Cancellation of Restricted Stock Options and Repurchase of Restricted Stocks of Hubei Jumpcan Pharmaceutical Co., Ltd.'s 2022 Restricted Stock and Stock Option Incentive Plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.